STACEY-ANN RHODD: Open Payments
NPI 1164492724 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,152 in 39 payments from 14 companies in 2025. Trend: 2023 $995 · 2024 $1,570 · 2025 $1,152
Food & beverage: $1,152
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $307 |
| Daiichi Sankyo Inc. | 5 | $133 |
| GENZYME CORPORATION | 2 | $128 |
| Pharmacosmos Therapeutics Inc. | 4 | $111 |
| Merck Sharp & Dohme LLC | 4 | $106 |
| SOBI, INC | 5 | $105 |
| AstraZeneca Pharmaceuticals LP | 3 | $86 |
| PharmaEssentia USA Corporation | 2 | $45 |
| Blueprint Medicines Corporation | 1 | $28 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
Products named: RYBREVANT, ENHERTU, MONOFERRIC, DARZALEX, Doptelet, INJECTAFER, LYNPARZA, KEYTRUDA.
Industry payments across FL — which companies pay providers there.
